Virginia Schmith

Title: Virginia Schmith: Innovator in ADHD Treatment

Introduction

Virginia Schmith is a notable inventor based in Wrightsville Beach, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of attention deficit/hyperactivity disorder (ADHD). Her innovative work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Virginia Schmith holds a patent for the "Mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)." This invention relates to a modified-release composition of mazindol, which is utilized in treating attention deficit disorders (ADD) or ADHD. The patent addresses related issues such as incoercible sleepiness, decline of vigilance, and excessive daytime sleepiness, particularly in children, adolescents, and adults.

Career Highlights

Virginia Schmith is associated with NLS Pharmaceutics AG, where she continues to advance her research and development efforts. Her work focuses on creating effective treatments for ADHD, showcasing her dedication to improving patient outcomes.

Collaborations

Virginia has collaborated with notable colleagues, including Alexander C. Zwyer and Scott Brantley. These partnerships have contributed to her innovative research and the development of her patented treatments.

Conclusion

Virginia Schmith is a pioneering inventor whose work in ADHD treatment exemplifies the impact of innovation in healthcare. Her contributions are vital in addressing the challenges faced by individuals with attention deficit disorders.